Now the FT chimes in as well


When an industry model is broken, the best business strategy may be to manage its decline.


http://www.ft.com/cms/s/0/6b2e1aa6-33d6-11e0-b1ed-00144feabdc0.html#axzz1DT3rXsjE

Nature looks at Big Pharma

"The pharma industry is deciding its core capabilities are marketing and dealing with regulatory bodies," says Judy Slinn, a business historian at Oxford Brooks University, UK. "Pharma companies will still do development work. They won't do discovery." 


Source

"Someone Is Making A Big Profit Out Of Woo Woo"

Meanwhile, my employer gets a $1.50 dispensing fee from your warfarin prescription:

Sex, Lies & Pharmaceuticals: How drug companies plan to profit from Female Sexual Dysfunction by Ray Moynihan and Dr Barbara Mintzes

Sex, Lies & Pharmaceuticals: How drug companies plan to profit from Female Sexual Dysfunction

by Ray Moynihan and Dr Barbara Mintzes

A provocative exposé of the lucrative industry being built around a newly constructed condition.
Against a backdrop of virtual intercourse, online porn, and burgeoning Viagra sales, Sex, Lies, and Pharmaceuticals reveals how women’s sexual difficulties are being repackaged as symptoms of a new disorder. In this compelling book, award-winning journalist Ray Moynihan teams up with drug assessment specialist Barbara Mintzes to investigate the creation of female sexual dysfunction or FSD, and the marketing machine that promises to “cure” it. The authors go inside the corridors of medical power to visit drug company–sponsored scientific meetings and medical education events where doctors are being trained to see women’s sexual problems as the symptoms of FSD — a pharmaceutically treatable condition. Moynihan and Mintzes explore the underlying causes of sexual dissatisfaction among women and expose how global drug companies exploit those problems in an attempt to create the next billion dollar disease.
via raymoynihan.com

Orgasm Inc - the trailer


Subscribe to: Posts (Atom)